First-of-its-kind small molecule therapy targets protein misfolding at the root of RHO-adRP

Sumitomo Pharma Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.